The objective of this study is to evaluate the effect of calorie and fat content on the pharmacokinetics of Lurasidone HCl in subjects with schizophrenia, schizoaffective disorder, or schizophreniform disorder.
Study Type
INTERVENTIONAL
Enrollment
26
California Clinical Trials
Glendale, California, United States
Clinical Research Institute
Wichita, Kansas, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.